BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 27021232)

  • 21. P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies.
    Xu ZG; Ryu DR; Yoo TH; Jung DS; Kim JJ; Kim HJ; Choi HY; Kim JS; Adler SG; Natarajan R; Han DS; Kang SW
    Nephrol Dial Transplant; 2005 Mar; 20(3):524-31. PubMed ID: 15647309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway.
    Trohatou O; Tsilibary EF; Charonis A; Iatrou C; Drossopoulou G
    J Cell Mol Med; 2017 Oct; 21(10):2599-2609. PubMed ID: 28664547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors.
    Abdel-Rahman EM; Abadir PM; Siragy HM
    Am J Physiol Regul Integr Comp Physiol; 2008 Nov; 295(5):R1473-8. PubMed ID: 18799632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 12/15-lipoxygenase inhibitors in diabetic nephropathy in the rat.
    Ma J; Natarajan R; LaPage J; Lanting L; Kim N; Becerra D; Clemmons B; Nast CC; Surya Prakash GK; Mandal M; Adler SG
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jan; 72(1):13-20. PubMed ID: 15589395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD
    Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy.
    Satoh M; Fujimoto S; Arakawa S; Yada T; Namikoshi T; Haruna Y; Horike H; Sasaki T; Kashihara N
    Nephrol Dial Transplant; 2008 Dec; 23(12):3806-13. PubMed ID: 18596126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis occurs differentially according to glomerular size in diabetic kidney disease.
    Jung DS; Lee SH; Kwak SJ; Li JJ; Kim DH; Nam BY; Kang HY; Chang TI; Park JT; Han SH; Yoo TH; Kang SW
    Nephrol Dial Transplant; 2012 Jan; 27(1):259-66. PubMed ID: 21652547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Losartan, an Angiotensin type I receptor, restores erectile function by downregulation of cavernous renin-angiotensin system in streptozocin-induced diabetic rats.
    Yang R; Yang B; Wen Y; Fang F; Cui S; Lin G; Sun Z; Wang R; Dai Y
    J Sex Med; 2009 Mar; 6(3):696-707. PubMed ID: 19175863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis.
    Mahmood J; Khan F; Okada S; Kumagai N; Morioka T; Oite T
    Kidney Int; 2006 Nov; 70(9):1591-8. PubMed ID: 16985512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells.
    Reddy MA; Adler SG; Kim YS; Lanting L; Rossi J; Kang SW; Nadler JL; Shahed A; Natarajan R
    Am J Physiol Renal Physiol; 2002 Nov; 283(5):F985-94. PubMed ID: 12372774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
    Whaley-Connell A; Nistala R; Habibi J; Hayden MR; Schneider RI; Johnson MS; Tilmon R; Rehmer N; Ferrario CM; Sowers JR
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F655-61. PubMed ID: 20007350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.
    Jourdan T; Szanda G; Rosenberg AZ; Tam J; Earley BJ; Godlewski G; Cinar R; Liu Z; Liu J; Ju C; Pacher P; Kunos G
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5420-8. PubMed ID: 25422468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
    Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall.
    Suzuki K; Han GD; Miyauchi N; Hashimoto T; Nakatsue T; Fujioka Y; Koike H; Shimizu F; Kawachi H
    Am J Pathol; 2007 Jun; 170(6):1841-53. PubMed ID: 17525253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effect on podocyte number in experimental diabetic nephropathy resulting from combined atrasentan and RAAS inhibition therapy.
    Hudkins KL; Wietecha TA; Steegh F; Alpers CE
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1295-F1305. PubMed ID: 32249614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.
    Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S
    Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes.
    Bai X; Li X; Tian J; Zhou Z
    PLoS One; 2014; 9(4):e96117. PubMed ID: 24759991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Slit diaphragm dysfunction in proteinuric states: identification of novel therapeutic targets for nephrotic syndrome.
    Kawachi H; Suzuki K; Miyauchi N; Hashimoto T; Otaki Y; Shimizu F
    Clin Exp Nephrol; 2009 Aug; 13(4):275-280. PubMed ID: 19266252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible role for glomerular-derived angiotensinogen in nephrotic syndrome.
    Yamazaki M; Fukusumi Y; Kayaba M; Kitazawa Y; Takamura S; Narita I; Kawachi H
    J Renin Angiotensin Aldosterone Syst; 2016 Oct; 17(4):. PubMed ID: 27932705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.